Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Prospective, Non-Comparative Study To Explore The Tolerability, Safety and Effectiveness Upon Transition to Paliperidone Slow-Release Tablet in Schizophrenic Patients

NCT00761579 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.

NCT NCT00761579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00761579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Prospective, Non-Comparative Study To Explore The Tolerability, Safety and Effectiveness Upon Transition to Paliperidone Slow-Release Tablet in Schizophrenic Patients
Lead sponsor
Janssen Korea, Ltd., Korea
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2008
Completion date
December 31, 2010
Enrollment
190 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia